Bonus BioGroup Ltd. (TLV:BONS)
25.10
-0.10 (-0.40%)
Aug 14, 2025, 12:11 PM IDT
Achilles Therapeutics Market Cap
Bonus BioGroup has a market cap or net worth of 294.32 million as of August 14, 2025. Its market cap has increased by 65.79% in one year.
Market Cap
294.32M
Enterprise Value
297.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$25.10
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 294.32M, an increase of 2,280.71%. That is a compound annual growth rate of 27.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 294.32M | 111.76% |
Dec 31, 2024 | 138.98M | -28.74% |
Dec 31, 2023 | 195.04M | -13.02% |
Dec 29, 2022 | 224.24M | -84.58% |
Dec 30, 2021 | 1.45B | 200.74% |
Dec 31, 2020 | 483.51M | 29.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 65.08B |
Danel (Adir Yeoshua) | 2.52B |
Kamada | 1.46B |
Bait Bakfar | 1.06B |
SofWave Medical | 980.58M |
BrainsWay | 788.58M |
Novolog (Pharm-Up 1966) | 709.61M |
Ilex Medical | 671.29M |